Role of transrectal ultrasonography in the prediction of prostate cancer: Artificial neural network analysis

Journal of Ultrasound in Medicine

Volumn 25, Issue 7, 2006, Pages 815-821

  Lee, Hak Jong ^a,b,c   Kim, Kwang Gi ^c   Lee, Sang Eun ^a   Byun, Seok Soo ^a   Hwang, Sung Il ^d   Jung, Sung Il ^e   Hong, Sung Kyu ^a   Kim, Seung Hyup ^c  

^a Seoul National University Bundang Hospital   (South Korea)

^b Seoul National University College of Medicine   (South Korea)

^c Seoul National University Hospital   (South Korea)

^d Hallym University   (South Korea)

^e Sungkyunkwan University School of Medicine   (South Korea)

Author keywords

Cancer; Neural networks; Prostate cancer; Transrectal ultrasonography

Indexed keywords

ANTIGENS; BIOPSY; NEURAL NETWORKS; PHYSIOLOGICAL MODELS; ULTRASONIC IMAGING;

PROSTATE CANCER; PROSTATE-SPECIFIC ANTIGEN (PSA); TRANSRECTAL ULTRASONOGRAPHIC (TRUS);

TUMORS;

PROSTATE SPECIFIC ANTIGEN;

ADULT; AGED; ARTICLE; ARTIFICIAL NEURAL NETWORK; BIOPSY GUN; DEVICE; DIAGNOSTIC IMAGING; DIGITAL RECTAL EXAMINATION; HUMAN; MAJOR CLINICAL STUDY; MALE; PREDICTION; PROSTATE BIOPSY; PROSTATE CANCER; TRANSRECTAL ULTRASONOGRAPHY; ULTRASOUND;

EID: 33745700788     PISSN: 02784297     EISSN: None     Source Type: Journal    
DOI: 10.7863/jum.2006.25.7.815     Document Type: Article

References (21)

1. Stephan C, Jung K, Cammann H, et al. An artificial neural network considerably improves the diagnostic power of percent free prostate-specific antigen in prostate cancer diagnosis: results of a 5-year investigation. Int J Cancer 2002; 99:466-473.
2. Arcangeli CG, Ornstein DK, Keetch DW, Andriole GL. Prostate-specific antigen in serum as a screening test for prostate cancer: the United States experience. Urol Clin North Am 1997; 24:299-306.
3. Catalona WJ, Smith DS, Ornstein DK. Prostate cancer detection in men with serum PSA concentrations 2.6 to 4.0 ng/mL and benign prostate examination: enhancement of specificity with free PSA measurements. JAMA 1997; 277:1452-1455.
4. Nadler RB, Humphrey PA, Smith DS, Catalona WJ, Ratliff TL. Effect of inflammation and benign prostatic hyperplasia on elevated serum prostate-specific antigen levels. J Urol 1995; 154:407-413.
5. Deliveliotis C, Alivizatos G, Stavropoulos NJ, et al. Influence of digital examination, cystoscopy, transrectal ultrasonography and needle biopsy on the concentration of prostate specific antigen. Urol Int 1994; 53:186-190.
6. Polascik TJ, Oesterling JE, Partin AW. Prostate specific antigen: a decade of discovery-what we have learned and where we are going. J Urol 1999; 162:293-306.
7. Snow PB, Smith DS, Catalona WJ. Artificial neural networks in the diagnosis and prognosis of prostate cancer: a pilot study. J Urol 1994; 152:1923-1926.
8. Stephan C, Cammann H, Semjonow A, et al. Multicenter evaluation of an artificial neural network to increase the prostate cancer detection rate and reduce unnecessary biopsies. Clin Chem 2002; 48:1279-1287.
9. Carlson GD, Calvanese CB, Partin AW. An algorithm combining age, total prostate-specific antigen (PSA), and percent free PSA to predict prostate cancer: results on 4289 cases. Urology 1998; 52:455-461.
10. Virtanen A, Gomari M, Kranse R, Stenman UH. Estimation of prostate cancer probability by logistic regression: free and total prostate-specific antigen, digital rectal examination, and heredity are significant variables. Clin Chem 1999; 45:987-994.
11. Finne P, Finne R, Auvinen A, et al. Predicting the outcome of prostate biopsy in screen-positive men by a multilayer perceptron network. Urology 2000; 56:418-422.
12. Loch T, Leuschner I, Genberg C, et al. Artificial neural network analysis (ANNA) of prostatic transrectal ultrasound. Prostate 1999; 39:198-204.
13. Wei JT, Zhang Z, Barnhill SD, Madyastha KR, Zhang H, Oesterling JE. Understanding artificial neural networks and exploring their potential applications for the practicing urologist. Urology 1998; 52:161-172.
14. Djavan B, Remzi M, Zlotta A, Seitz C, Snow P, Marberger M. Novel artificial neural network for early detection of prostate cancer. J Clin Oncol 2002; 20:921-929.
15. Metz CE, Herman BA, Roe CA. Statistical comparison of two ROC-curve estimates obtained from partially-paired datasets. Med Decis Making 1998; 18:110-121.
16. Ronco AL, Fernandez R. Improving ultrasonographic diagnosis of prostate cancer with neural networks. Ultrasound Med Biol 1999; 25:729-733.
17. Sargent DJ. Comparison of artificial neural networks with other statistical approaches. Cancer 2001; 91:1636-1642.
18. Veltri RW, Chaudhari M, Miller MC, Poole EC, O'Dowd GJ, Partin AW. Comparison of logistic regression and neural net modeling for prediction of prostate cancer pathologic stage. Clin Chem 2002; 48:1828-1834.
19. Babaian RJ, Fritsche H, Ayala A, et al. Performance of a neural network in detecting prostate cancer in the prostate-specific antigen reflex range of 2.5 to 4.0 ng/mL Urology 2000; 56:1000-1006.
20. Terris MK. Ultrasonography and biopsy of the prostate. In: Retik AB, Vaughan ED, Wein AJ (eds). Campbell's Urology. 8th ed. Philadelphia, PA: Elsevier Science; 2002:3038-3054.
21. Cho JY, Kim SH, Lee SE. Peripheral hypoechoic lesions of the prostate: evaluation with color and power Doppler ultrasound. Eur Urol 2000; 37:443-448.